• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱尿路上皮乳头状瘤与低恶性潜能乳头状肿瘤的免疫组化鉴别

Immunohistochemical Differentiation between Urothelial Papillomas and Papillary Neoplasms of Low Malignant Potential of the Urinary Bladder.

作者信息

Alrashidy Mohammed, Atef Aliaa, Baky Tarek Abdel

机构信息

Department of Pathology, Faculty of Medicine, University of Tanta, Tanta, Egypt E-mail :

出版信息

Asian Pac J Cancer Prev. 2016;17(4):1769-72. doi: 10.7314/apjcp.2016.17.4.1769.

DOI:10.7314/apjcp.2016.17.4.1769
PMID:27221850
Abstract

BACKGROUND

Urothelial papilloma and non-invasive papillary carcinoma are common neoplasms of the urinary bladder. Distinguishing papillomas and papillary carcinomas, especially the low grade type, is often debatable on the basis of histological features alone.

MATERIALS AND METHODS

We investigated immunohistochemical expression of cytokeratin 20 (CK20), p53, and Ki-67 in a group of 20 urothelial papilloma cases and 30 noninvasive papillary neoplasms of low malignant potential (PNLMP) of the urinary bladder. Whole tissue sections were examined.

RESULTS

Among the 30 carcinoma cases, 12 (40%) showed strong reactivity for the whole panel, 16 (53%) reacted positively for two markers, and 2 (7%) reacted just to one of them. Ki-67 was considered positive in 27 cases (90%) and p53 in 24 (80%), CK20 showed positive reactivity in 21 cases (70%). Only small percentages of papillomas were positive, and then only weakly.

CONCLUSIONS

We concluded that the intense positivity of suspicious cells for at least one of these markers would confirm the presence of malignant changes and favours the diagnosis of carcinoma.

摘要

背景

尿路上皮乳头状瘤和非浸润性乳头状癌是膀胱常见的肿瘤。仅根据组织学特征区分乳头状瘤和乳头状癌,尤其是低级别类型,往往存在争议。

材料与方法

我们研究了20例尿路上皮乳头状瘤病例和30例膀胱低恶性潜能非浸润性乳头状肿瘤(PNLMP)中细胞角蛋白20(CK20)、p53和Ki-67的免疫组化表达。对全组织切片进行检查。

结果

在30例癌病例中,12例(40%)对全部标记物呈强反应性,16例(53%)对两种标记物呈阳性反应,2例(7%)仅对其中一种呈阳性反应。Ki-67在27例(90%)中被认为呈阳性,p53在24例(80%)中呈阳性,CK20在21例(70%)中呈阳性反应。只有小部分乳头状瘤呈阳性,且反应较弱。

结论

我们得出结论,可疑细胞对这些标记物中至少一种呈强阳性将证实存在恶性改变,有助于癌的诊断。

相似文献

1
Immunohistochemical Differentiation between Urothelial Papillomas and Papillary Neoplasms of Low Malignant Potential of the Urinary Bladder.膀胱尿路上皮乳头状瘤与低恶性潜能乳头状肿瘤的免疫组化鉴别
Asian Pac J Cancer Prev. 2016;17(4):1769-72. doi: 10.7314/apjcp.2016.17.4.1769.
2
Immunohistochemical Expression of Cyclin D1, Cytokeratin 20, and Uroplakin III in Proliferative Urinary Bladder Lesions Induced by o-Nitroanisole in Fischer 344/N Rats.邻硝基苯甲醚诱导Fischer 344/N大鼠膀胱增殖性病变中细胞周期蛋白D1、细胞角蛋白20和尿血小板膜蛋白Ⅲ的免疫组化表达
Vet Pathol. 2016 May;53(3):682-90. doi: 10.1177/0300985815603432. Epub 2015 Aug 28.
3
Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia.细胞角蛋白20和CD44蛋白表达与WHO/ISUP分级在pTa和pT1乳头状尿路上皮肿瘤中的关系。
Mod Pathol. 2000 Dec;13(12):1315-23. doi: 10.1038/modpathol.3880241.
4
Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur.成纤维细胞生长因子受体3的强免疫组化表达、细胞角蛋白20的浅表染色模式以及低增殖活性可确定那些不会复发的低恶性潜能乳头状尿路上皮肿瘤。
Cancer. 2008 Feb 1;112(3):636-44. doi: 10.1002/cncr.23212.
5
Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis.具有内翻性生长模式的尿路上皮癌可通过荧光原位杂交、免疫组织化学和形态学分析与内翻性乳头状瘤相鉴别。
Am J Surg Pathol. 2007 Dec;31(12):1861-7. doi: 10.1097/PAS.0b013e318060cb9d.
6
Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.Ki-67 MIB1标记指数与原发性膀胱TaT1尿路上皮细胞癌的预后
J Clin Pathol. 2006 Jan;59(1):83-8. doi: 10.1136/jcp.2004.022939.
7
Correlation of Ki-67 and p53 with the new World Health Organization/International Society of Urological Pathology Classification System for Urothelial Neoplasia.Ki-67和p53与世界卫生组织/国际泌尿病理学会尿路上皮肿瘤新分类系统的相关性
Arch Pathol Lab Med. 2001 May;125(5):646-51. doi: 10.5858/2001-125-0646-COKAPW.
8
Clinicopathologic study of 60 cases of urothelial neoplasms with inverted growth patterns: Reclassification by international consultation on urologic disease (ICUD) recommendations.60 例具有倒置生长模式的尿路上皮肿瘤的临床病理研究:根据国际泌尿疾病咨询委员会 (ICUD) 建议进行的重新分类。
Ann Diagn Pathol. 2020 Feb;44:151433. doi: 10.1016/j.anndiagpath.2019.151433. Epub 2019 Nov 22.
9
FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours.FGFR3突变和正常的CK20染色模式可界定低级别非侵袭性膀胱尿路上皮肿瘤。
Eur Urol. 2007 Sep;52(3):760-8. doi: 10.1016/j.eururo.2007.01.009. Epub 2007 Jan 12.
10
[Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].[具有内生性生长模式的尿路上皮增生性病变:一项临床病理研究]
Zhonghua Bing Li Xue Za Zhi. 2011 May;40(5):319-23.